Skip to main content
Industry News
Dexcom's continuous glucose monitoring system cleared by FDA

Dexcom has obtained 510(k) clearance from the FDA for its G6 Pro Continuous Glucose Monitoring System, which gathers real-time glucose data for 10 days in a blinded and unblinded mode. The device is indicated for patients ages two years and older.

Full Story: